{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:37:31Z","timestamp":1760783851698},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2014,8,17]],"date-time":"2014-08-17T00:00:00Z","timestamp":1408233600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1007\/s12032-014-0167-5","type":"journal-article","created":{"date-parts":[[2014,8,16]],"date-time":"2014-08-16T03:04:59Z","timestamp":1408158299000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Expression of serum survivin protein in diagnosis and prognosis of gallbladder cancer: a comparative study"],"prefix":"10.1007","volume":"31","author":[{"given":"Jaya","family":"Nigam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhijit","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hasan Raza","family":"Kazmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anshuman","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vishal","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devendra","family":"Parmar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manoj Kumar","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,8,17]]},"reference":[{"issue":"2","key":"167_CR1","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0092-8674(00)80564-4","volume":"96","author":"DL Vaux","year":"1999","unstructured":"Vaux DL, Korsmeyer SJ. Cell death in development. Cell. 1999;96(2):245\u201354.","journal-title":"Cell"},{"issue":"1","key":"167_CR2","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0304-3835(02)00190-8","volume":"184","author":"N Takai","year":"2002","unstructured":"Takai N, Miyazaki T, Nishida M, Nasu K, Miyakawa I. Survivin expression correlates with clinical stage, histological grade, invasive behavior and survival rate in endometrial carcinoma. Cancer Lett. 2002;184(1):105\u201316.","journal-title":"Cancer Lett"},{"issue":"7","key":"167_CR3","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1200\/JCO.1999.17.7.2100","volume":"17","author":"M Monz\u00f3","year":"1999","unstructured":"Monz\u00f3 M, Rosell R, Felip E, Astudillo J, S\u00e1nchez JJ, Maestre J, et al. A novel anti-apoptosis gene: re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers. J Clin Oncol. 1999;17(7):2100\u20134.","journal-title":"J Clin Oncol"},{"issue":"1","key":"167_CR4","first-page":"127","volume":"6","author":"K Tanaka","year":"2000","unstructured":"Tanaka K, Iwamoto S, Gon G, Nohara T, Iwamoto M, Tanigawa N. Expression of survivin and its relationship to loss of apoptosis in breast carcinomas. Clin Cancer Res. 2000;6(1):127\u201334.","journal-title":"Clin Cancer Res"},{"issue":"8","key":"167_CR5","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/sj.bjc.6600546","volume":"87","author":"M Ikeguchi","year":"2002","unstructured":"Ikeguchi M, Kaibara N. Survivin messenger RNA expression is a good prognostic biomarker for oesophageal carcinoma. Br J Cancer. 2002;87(8):883\u20137.","journal-title":"Br J Cancer"},{"issue":"9","key":"167_CR6","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1002\/cncr.10898","volume":"95","author":"M Ikeguchi","year":"2002","unstructured":"Ikeguchi M, Hirooka Y, Kaibara N. Quantitative analysis of apoptosis-related gene expression in hepatocellular carcinoma. Cancer. 2002;95(9):1938\u201345.","journal-title":"Cancer"},{"issue":"11","key":"167_CR7","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1111\/j.1349-7006.2000.tb00906.x","volume":"91","author":"K Asanuma","year":"2000","unstructured":"Asanuma K, Moriai R, Yajima T, Yagihashi A, Yamada M, Kobayashi D, et al. Survivin as a radioresistance factor in pancreatic cancer. Jpn J Cancer Res. 2000;91(11):1204\u20139.","journal-title":"Jpn J Cancer Res"},{"issue":"9106","key":"167_CR8","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0140-6736(05)70294-4","volume":"351","author":"C Adida","year":"1998","unstructured":"Adida C, Berrebi D, Peuchmaur M, Reyes-Mugica M, Altieri DC. Anti-apoptosis gene, survivin, and prognosis of neuroblastoma. Lancet. 1998;351(9106):882\u20133.","journal-title":"Lancet"},{"issue":"3","key":"167_CR9","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1006\/exmp.2001.2367","volume":"70","author":"L Lo Muzio","year":"2001","unstructured":"Lo Muzio L, Staibano S, Pannone G, Mignogna MD, Mariggi\u00f2 A, Salvatore G, et al. Expression of the apoptosis inhibitor survivin in aggressive squamous cell carcinoma. Exp Mol Pathol. 2001;70(3):249\u201354.","journal-title":"Exp Mol Pathol"},{"issue":"7","key":"167_CR10","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1200\/JCO.1999.17.7.2100","volume":"17","author":"M Monz\u00f3","year":"1999","unstructured":"Monz\u00f3 M, Rosell R, Felip E, Astudillo J, S\u00e1nchez JJ, Maestre J, et al. A novel anti-apoptosis gene: re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers. J Clin Oncol. 1999;17(7):2100\u20134.","journal-title":"J Clin Oncol"},{"issue":"22","key":"167_CR11","first-page":"5071","volume":"58","author":"H Kawasaki","year":"1998","unstructured":"Kawasaki H, Altieri DC, Lu CD, Toyoda M, Tenjo T, Tanigawa N. Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. Cancer Res. 1998;58(22):5071\u20134.","journal-title":"Cancer Res"},{"issue":"1","key":"167_CR12","first-page":"127","volume":"6","author":"K Tanaka","year":"2000","unstructured":"Tanaka K, Iwamoto S, Gon G, Nohara T, Iwamoto M, Tanigawa N. Expression of survivin and its relationship to loss of apoptosis in breast carcinomas. Clin Cancer Res. 2000;6(1):127\u201334.","journal-title":"Clin Cancer Res"},{"issue":"10","key":"167_CR13","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1101\/gad.9.10.1149","volume":"9","author":"CJ Sherr","year":"1995","unstructured":"Sherr CJ, Roberts JM. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 1995;9(10):1149\u201363.","journal-title":"Genes Dev"},{"issue":"10","key":"167_CR14","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1084\/jem.20032033","volume":"199","author":"F Altznauer","year":"2004","unstructured":"Altznauer F, Martinelli S, Yousefi S, Th\u00fcrig C, Schmid I, Conway EM, et al. Inflammation-associated cell cycle-independent block of apoptosis by survivin in terminally differentiated neutrophils. J Exp Med. 2004;199(10):1343\u201354.","journal-title":"J Exp Med"},{"issue":"6","key":"167_CR15","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","volume":"17","author":"SB Edge","year":"2010","unstructured":"Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17(6):1471\u20134.","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"167_CR16","first-page":"198","volume":"18","author":"HS Shukla","year":"1981","unstructured":"Shukla HS, Awasthi K, Naithani YP, Gupta SC. A clinico-pathological study of carcinoma of the gall bladder. Indian J Cancer. 1981;18(3):198\u2013201.","journal-title":"Indian J Cancer"},{"issue":"3","key":"167_CR17","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1470-2045(03)01021-0","volume":"4","author":"S Misra","year":"2003","unstructured":"Misra S, Chaturvedi A, Misra NC, Sharma ID. Carcinoma of the gallbladder. Lancet Oncol. 2003;4(3):167\u201376.","journal-title":"Lancet Oncol"},{"issue":"3","key":"167_CR18","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000353133","volume":"30","author":"HR Kazmi","year":"2013","unstructured":"Kazmi HR, Chandra A, Nigam J, Noushif M, Parmar D, Gupta V. Prognostic significance of K-ras codon 12 mutation in patients with resected gallbladder cancer. Dig Surg. 2013;30(3):233\u20139.","journal-title":"Dig Surg"},{"issue":"6","key":"167_CR19","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nrc3066","volume":"11","author":"H Schwarzenbach","year":"2011","unstructured":"Schwarzenbach H, Hoon DS, Pantel K. Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer. 2011;11(6):426\u201337.","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"167_CR20","doi-asserted-by":"crossref","first-page":"e46737","DOI":"10.1371\/journal.pone.0046737","volume":"7","author":"S Khan","year":"2012","unstructured":"Khan S, Jutzy JM, Valenzuela MM, Turay D, Aspe JR, Ashok A, et al. Plasma-derived exosomal survivin, a plausible biomarker for early detection of prostate cancer. PLoS One. 2012;7(10):e46737.","journal-title":"PLoS One"},{"issue":"3","key":"167_CR21","first-page":"1098","volume":"9","author":"M Kappler","year":"2003","unstructured":"Kappler M, Kotzsch M, Bartel F, F\u00fcssel S, Lautenschl\u00e4ger C, Schmidt U, et al. Elevated expression level of survivin protein in soft-tissue sarcomas is a strong independent predictor of survival. Clin Cancer Res. 2003;9(3):1098\u2013104.","journal-title":"Clin Cancer Res"},{"issue":"9","key":"167_CR22","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/01.meg.0000230086.83792.56","volume":"18","author":"GH Lee","year":"2006","unstructured":"Lee GH, Joo YE, Koh YS, Chung IJ, Park YK, Lee JH, et al. Expression of survivin in gastric cancer and its relationship with tumor angiogenesis. Eur J Gastroenterol Hepatol. 2006;18(9):957\u201363.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"8","key":"167_CR23","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1002\/ijc.24516","volume":"125","author":"T Wang","year":"2009","unstructured":"Wang T, Qian X, Wang Z, Wang L, Yu L, Ding Y, et al. Detection of cell-free BIRC5 mRNA in effusions and its potential diagnostic value for differentiating malignant and benign effusions. Int J Cancer. 2009;125(8):1921\u20135.","journal-title":"Int J Cancer"},{"issue":"3","key":"167_CR24","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1001\/jama.285.3.324","volume":"285","author":"SD Smith","year":"2001","unstructured":"Smith SD, Wheeler MA, Plescia J, Colberg JW, Weiss RM, Altieri DC. Urine detection of survivin and diagnosis of bladder cancer. JAMA. 2001;285(3):324\u20138.","journal-title":"JAMA"},{"issue":"2","key":"167_CR25","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.canlet.2008.08.023","volume":"273","author":"YK Wu","year":"2009","unstructured":"Wu YK, Chen KT, Kuo YB, Huang YS, Chan EC. Quantitative detection of survivin in malignant pleural effusion for the diagnosis and prognosis of lung cancer. Cancer Lett. 2009;273(2):331\u20135.","journal-title":"Cancer Lett"},{"issue":"20","key":"167_CR26","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.3748\/wjg.v13.i20.2784","volume":"13","author":"TT Wang","year":"2007","unstructured":"Wang TT, Qian XP, Liu BR. Survivin: potential role in diagnosis, prognosis and targeted therapy of gastric cancer. World J Gastroenterol. 2007;13(20):2784\u201390.","journal-title":"World J Gastroenterol"},{"key":"167_CR27","author":"J Nigam","year":"2014","unstructured":"Nigam J, Chandra A, Kazmi HR, Parmar D, Singh D, Gupta V, et al. Expression of survivin mRNA in gallbladder cancer: a diagnostic and prognostic marker? Tumour Biol. 2014. doi: 10.1007\/s13277-014-2200-x .","journal-title":"Tumour Biol"},{"issue":"1","key":"167_CR28","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s12032-013-0775-5","volume":"31","author":"P Chen","year":"2014","unstructured":"Chen P, Zhu J, Liu DY, Li HY, Xu N, Hou M. Over-expression of survivin and VEGF in small-cell lung cancer may predict the poorer prognosis. Med Oncol. 2014;31(1):775.","journal-title":"Med Oncol"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-014-0167-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-014-0167-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-014-0167-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T22:19:23Z","timestamp":1565734763000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-014-0167-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,17]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["167"],"URL":"https:\/\/doi.org\/10.1007\/s12032-014-0167-5","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,17]]},"article-number":"167"}}